BIT
CRVS icon

BlackRock Institutional Trust’s Corvus Pharmaceuticals CRVS Stock Holding History

BlackRock Institutional Trust’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$523K Buy
36,583
+1,252
+4% +$19K ﹤0.01% 3448
2016
Q3 		$581K Sell
35,331
-403
-1% -$5.81K ﹤0.01% 3452
2016
Q2 		$510K Buy
35,734
+32,710
+1,082% +$442K ﹤0.01% 3490
2016
Q1 		$44K Buy
+3,024
New +$43.4K ﹤0.01% 3799

Other funds holding CRVS

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Institutional Trust's CRVS Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Corvus Pharmaceuticals (CRVS) stake by 3.5% in Q4 2016, buying an estimated $19K and bringing the position to 36,583 shares worth $523K. The position accounts for ﹤0.01% of the portfolio, ranked #3448.

BlackRock Institutional Trust first reported a position in CRVS in Q1 2016 and has held it in 4 quarters since. The position peaked at $581K in Q3 2016. 53 funds tracked by Wall St. Rank hold CRVS as of Q4 2016.

  • BlackRock Institutional Trust held 36,583 shares of Corvus Pharmaceuticals worth $523K as of Q4 2016.
  • BlackRock Institutional Trust bought 1,252 Corvus Pharmaceuticals shares in Q4 2016, an estimated $19K.
  • Corvus Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3448 holding.
  • BlackRock Institutional Trust first reported a position in Corvus Pharmaceuticals in Q1 2016 and has held it in 4 quarters since.
  • BlackRock Institutional Trust's Corvus Pharmaceuticals position peaked at $581K in Q3 2016.
  • 53 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.